Monthly Archives: December 2019

ILN Today Post

Cleaver Fulton Rankin advises InfraStrata on acquisition of Harland and Wolff

Cleaver Fulton Rankin has played an integral role in the acquisition of Harland and Wolff Industries by London-based energy firm, InfraStrata.

Since its Norwegian parent company collapsed, Harland and Wolff went into administration in August.

Read full article
ILN Today Post

Ahlawat & Associates ranked amongst Top 50 law firms in India by RSG Consulting

We are pleased and delighted to share with you that Ahlawat & Associates has been ranked amongst the top 50 law firms of 2019 by RSG Consulting in its India Report.

The rankings were unveiled at the RSG India Summit held on 26th November 2019 at the Four Seasons Hotel in Mumbai. RSG rankings are widely considered to be the most robust ranking of Indian law firms and is even used by the UK and Indian governments and academic institutions such as Harvard University as a source of reference. The rankings are conducted every alternate year and are based on number of deals, client satisfaction reviews and practice areas among other things.

Provided below is the link to the rankings: 

https://www.rsgindiareport.com/the-rsg-top-50-2019

Read full article

Lidings Demonstrates New Achievements and Takes Advanced Positions in Pravo.ru–300 Rating in 2019

Ritz Carlton Moscow, December 5th 2019. The results of the annual Pravo.ru-300 law firms’ ranking were announced at an awarding ceremony at the Ritz Carlton Moscow. Based on the analytical research reflecting on the latest tendencies in the country’s legal market, Lidings once again takes top positions in the rating of the legal advisors in Russia.
Read full article

Don’t read this after 6:00 p.m.! The right to disconnect

By Eliab Taïrou, from our Labour and Employment Law Practice Group

December 4, 2019 —

Hyperconnectivity

It goes without saying that we live in a world that has become “hyper-connected”, as we are constantly staring at our cell phones or other electronic devices. Many employees find themselves, outside of office hours, constantly responding to emails and requests from their employer, colleagues or clients.

Read full article

Monitoring ERISA Investment Fiduciaries

Fiduciaries of employee benefit plans subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) that appoint investment managers (“Appointing Fiduciaries”) will be interested in the opinion of the U.S. District Court for the Western District of Pennsylvania in Scalia v. WPN Corporation, et al (“WPN”) regarding their duty to monitor investment fiduciaries.  Given the potential risk related to a breach this fiduciary duty, the WPN opinion is likely to be an important one for Appointing Fiduciaries.

Read full article

MISSING: Business Development Motivation. 4 Tips to Find it this December!

It’s the last month of the year, and I can feel your motivation for business development flagging. It’s okay, you’re not alone.

So how can you motivate yourself (or others) to finish out the year strong, and get some business development in? 

Read full article

Court to Consider Whether California Ride Share Drivers Who Make Airport Runs Are Exempt from the Federal Arbitration Act Continue Reading…

On November 26, 2019, San Francisco Superior Court Judge Richard B. Ulmer ruled that the Federal Arbitration Act (“FAA”) might not apply to Uber drivers who are engaged in interstate commerce while driving passengers to or from international airports.

In his claims before the Division of Labor Standards and Enforcement (“DLSE”), driver Sangam Patel (“Patel”) seeks recovery of unpaid wages, overtime pay, vacation pay, meal and rest break premiums, and unpaid business expenses allegedly owed by Uber. Uber petitioned to compel arbitration of Patel’s (“Patel”) claims under the FAA.

Read full article

After Decades of Broad Enforcement Discretion, FDA Signals New Approach to Homeopathic Drugs

Two announcements made by FDA in late October signal a marked change to FDA’s regulatory approach to “homeopathic” drugs. On October 25, 2019, FDA withdrew the 1988 Compliance Policy Guide (“CPG”) 400.400 Conditions Under Which Homeopathic Drugs May Be Marketed, and, concurrently, published revised draft guidance titled Drug Products Labeled as Homeopathic (the “Revised Homeopathic Draft Guidance”).

Read full article